Pages that link to "Q36739426"

The following pages link to Molecular and cellular immune mediators of neuroprotection (Q36739426):

Displaying 33 items.

• The neuropathology of autism: where do we stand? (Q22242617) (← links)
• Pathological and protective roles of glia in chronic pain (Q24646738) (← links)
• Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases (Q26785969) (← links)
• Inhibition of microglia activation as a phenotypic assay in early drug discovery (Q26996061) (← links)
• The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus (Q27318419) (← links)
• The yin and yang of microglia (Q27693871) (← links)
• Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation (Q28757375) (← links)
• RNase L mediated protection from virus induced demyelination (Q33508237) (← links)
• Purinergic signaling induces cyclooxygenase-1-dependent prostanoid synthesis in microglia: roles in the outcome of excitotoxic brain injury (Q34055792) (← links)
• TNF-α and Microglial Hormetic Involvement in Neurological Health & Migraine (Q34341918) (← links)
• Microglial phenotype and adaptation (Q34359569) (← links)
• Neuropeptide Y modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia. (Q34439028) (← links)
• Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection (Q35195927) (← links)
• Neuropeptide Y inhibits interleukin-1β-induced phagocytosis by microglial cells. (Q35617873) (← links)
• Noninvasive molecular imaging of neuroinflammation (Q36079268) (← links)
• Microglia and Astrocyte Activation by Toll-Like Receptor Ligands: Modulation by PPAR-gamma Agonists (Q36731548) (← links)
• Spinal cord injury: time to move? (Q36989202) (← links)
• Possible involvement of TLRs and hemichannels in stress-induced CNS dysfunction via mastocytes, and glia activation (Q37019818) (← links)
• Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner (Q37392519) (← links)
• The HPA - Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain (Q37689538) (← links)
• Targeting the hematopoietic system for the treatment of Alzheimer’s disease (Q37824968) (← links)
• The neuroendocrine control of the innate immune system in health and brain diseases (Q38020956) (← links)
• The emerging role of the receptor for advanced glycation end products on innate immunity (Q38165257) (← links)
• Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease. (Q38514940) (← links)
• Neuropeptide Y inhibits interleukin-1 beta-induced microglia motility (Q39456511) (← links)
• Ephedrannin A and B from roots of Ephedra sinica inhibit lipopolysaccharide-induced inflammatory mediators by suppressing nuclear factor-κB activation in RAW 264.7 macrophages (Q39645280) (← links)
• Neuroprotective Effects of Stem Cells in Ischemic Stroke (Q41026038) (← links)
• Neuroprotective role of Agmatine in Neurological Diseases. (Q48162433) (← links)
• Morphine preconditioning protects against LPS-induced neuroinflammation and memory deficit (Q48629661) (← links)
• Socioeconomic Deprivation, Adverse Childhood Experiences and Medical Disorders in Adulthood: Mechanisms and Associations (Q62675756) (← links)
• Gold ions bio-released from metallic gold particles reduce inflammation and apoptosis and increase the regenerative responses in focal brain injury (Q81429436) (← links)
• The Roles of MicroRNAs in Stroke: Possible Therapeutic Targets (Q88998651) (← links)
• Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA (Q89525425) (← links)